| Trial ID: | L3904 |
| Source ID: | NCT06241638
|
| Associated Drug: |
Vitamin B12 0.5 Mg/Actuat
|
| Title: |
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: Vitamin B12 0.5 MG/ACTUAT|DRUG: Dapagliflozin 10mg Tab
|
| Outcome Measures: |
Primary: HbA1c in the two groups, The diabetic status in the two groups was evaluated by measuring the HbA1c levels, One year |
|
| Sponsor/Collaborators: |
Sponsor: Al-Balqa Applied University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2022-07-01
|
| Completion Date: |
2023-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2024-02-05
|
| Locations: |
Walid Aburayyan, Salt, 961343, Jordan
|
| URL: |
https://clinicaltrials.gov/show/NCT06241638
|
